beta
![]()
TORC
resTORbio, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.
Market Cap: 83.1 Million
Primary Exchange: NASDAQ
Website: http://www.restorbio.com
Shares Outstanding: 36.5 Million
Float: 21.5 Million
Dividend: (%)
Beta: 0.7864147207857354
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 653 trading days
From: 2018-02-23 To: 2020-09-15
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|